GOSSAMER BIO INC (GOSS:NASDAQ)
$0.2179 -0.0021 (-0.9545%)
Analysed GOSSAMER BIO INC (GOSS:NASDAQ) News Sources
Kura Oncology (KURA) Reports Q1 Loss, Tops Revenue Estimates
12-05-2026
yahoo.com
Regenxbio (RGNX) Reports Q1 Loss, Lags Revenue Estimates
14-05-2026
yahoo.com
Gossamer Bio to Announce First Quarter 2026 Financial Results and Host Conference Call and Webcast on May 18, 2026
15-05-2026
yahoo.com
Gossamer Bio (GOSS) Reports Q1 Loss, Tops Revenue Estimates
15-05-2026
yahoo.com
Gossamer Bio Announces First Quarter 2026 Financial Results and Provides Business Update
18-05-2026
yahoo.com
Gossamer Bio, Inc. Launches Exchange Offer and Consent Solicitation Intended to Eliminate Over $120 Million of Debt with Existing Noteholder Support
18-05-2026
yahoo.com
Gossamer Bio Q1 Earnings Call Highlights
18-05-2026
marketbeat.com
Gossamer Bio Shares Decline After Wider-Than-Expected Q1 Loss Despite Revenue Beat (GOSS)
18-05-2026
advfn.com
Pulmonary Arterial Hypertension Market Outlook Shows Strong Upward Trend at a CAGR of 6.7% During the Study Period (2022-2036) Supported by New Clinical Developments | DelveInsight
25-05-2026
yahoo.com
Gossamer Bio (GOSS) Q1 2026 Earnings Transcript
27-05-2026
fool.com
What is the current price of GOSSAMER BIO INC (GOSS:NASDAQ)?
The current price of GOSSAMER BIO INC (GOSS:NASDAQ) is $0.2179.
GOSSAMER BIO INC (GOSS:NASDAQ) absolute price change since previous trading day?
The absolute price change of GOSSAMER BIO INC (GOSS:NASDAQ) since the previous trading day is $-0.0021.
GOSSAMER BIO INC (GOSS:NASDAQ) percentage price change since previous trading day?
The percentage price change of GOSSAMER BIO INC (GOSS:NASDAQ) since the previous trading day is -0.9545%.
What is the most recent average sentiment score for GOSSAMER BIO INC (GOSS:NASDAQ)?
The most recent average sentiment score for GOSSAMER BIO INC (GOSS:NASDAQ) is 56 out of 100.
What is the most recent average sentiment for GOSSAMER BIO INC (GOSS:NASDAQ)?
The most recent sentiment for GOSSAMER BIO INC (GOSS:NASDAQ) is .
SEC-8K** Filing Available For GOSSAMER BIO INC (GOSS:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.